Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications

MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implicatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and translational gastroenterology 2021-10, Vol.12 (10), p.e00416-e00416
Hauptverfasser: Moret-Tatay, Inés, Cerrillo, Elena, Hervás, David, Iborra, Marisa, Sáez-González, Esteban, Forment, Javier, Tortosa, Luis, Nos, Pilar, Gadea, Jose, Beltrán, Belén
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e00416
container_issue 10
container_start_page e00416
container_title Clinical and translational gastroenterology
container_volume 12
creator Moret-Tatay, Inés
Cerrillo, Elena
Hervás, David
Iborra, Marisa
Sáez-González, Esteban
Forment, Javier
Tortosa, Luis
Nos, Pilar
Gadea, Jose
Beltrán, Belén
description MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications. Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used. Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year. Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.
doi_str_mv 10.14309/ctg.0000000000000416
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8547914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2769976248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</originalsourceid><addsrcrecordid>eNpdkV1vFCEUhidGY5u1P0EziRd6MxUYmAEvTJr1q0nVzVYT7wjLHGaoDKwwY-OF_126W5u1JCdAeM57OOctiqcYnWJaI_FKT_0pOlwUNw-KY4IZq2pOvz88OB8VJyld7SBEuBCPi6OaNoKhmh4Xfy63oK2xulw5lUZVfrI6hvXns_LS9l5Nc4RUWl-uInRWT9b3pfJduQze2DjeXJcxDP5FKt_aBCpBuQY9xwhew-tyHRzs-JWahtCDz3XOx62zWk02-PSkeGSUS3Byuy-Kb-_ffV1-rC6-fDhfnl1UmnLKKt4wlAM4JVQZ3Gw06TYb1DAOLeKmA6MI47URusOtUIRQAaxukVEZM6quF8Wbve523ozQafBTVE5uox1V_C2DsvL_F28H2YdfkjPaijzyRfHyViCGnzOkSY42aXBOeQhzkrl8Q3NJijL6_B56Feboc3uStI0QbUMozxTbU3naKUUwd5_BSO48ltljed_jnPfssJO7rH-OZoDugevgJojph5uvIcoBlJsGiXBLEBK0IohgfCNa5cCs_guJqbOk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2769976248</pqid></control><display><type>article</type><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</creator><creatorcontrib>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</creatorcontrib><description>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications. Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used. Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year. Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</description><identifier>ISSN: 2155-384X</identifier><identifier>EISSN: 2155-384X</identifier><identifier>DOI: 10.14309/ctg.0000000000000416</identifier><identifier>PMID: 34695034</identifier><language>eng</language><publisher>United States: Wolters Kluwer</publisher><subject>Adult ; Biomarkers ; Colonoscopy ; Colorectal surgery ; Crohn Disease - blood ; Crohn Disease - diagnostic imaging ; Crohn Disease - genetics ; Crohn Disease - surgery ; Crohn's disease ; Epigenetics ; Female ; Gene expression ; Health risks ; Humans ; Ileum - diagnostic imaging ; Inflammatory Bowel Disease ; Male ; MicroRNAs ; MicroRNAs - blood ; Middle Aged ; Nomograms ; Pathogenesis ; Postoperative period ; Reactive oxygen species ; Recurrence ; Risk Assessment ; Tumor necrosis factor-TNF ; Young Adult</subject><ispartof>Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00416-e00416</ispartof><rights>Wolters Kluwer</rights><rights>Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.</rights><rights>2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</citedby><cites>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</cites><orcidid>0000-0003-2086-1521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547914/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547914/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34695034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moret-Tatay, Inés</creatorcontrib><creatorcontrib>Cerrillo, Elena</creatorcontrib><creatorcontrib>Hervás, David</creatorcontrib><creatorcontrib>Iborra, Marisa</creatorcontrib><creatorcontrib>Sáez-González, Esteban</creatorcontrib><creatorcontrib>Forment, Javier</creatorcontrib><creatorcontrib>Tortosa, Luis</creatorcontrib><creatorcontrib>Nos, Pilar</creatorcontrib><creatorcontrib>Gadea, Jose</creatorcontrib><creatorcontrib>Beltrán, Belén</creatorcontrib><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><title>Clinical and translational gastroenterology</title><addtitle>Clin Transl Gastroenterol</addtitle><description>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications. Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used. Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year. Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</description><subject>Adult</subject><subject>Biomarkers</subject><subject>Colonoscopy</subject><subject>Colorectal surgery</subject><subject>Crohn Disease - blood</subject><subject>Crohn Disease - diagnostic imaging</subject><subject>Crohn Disease - genetics</subject><subject>Crohn Disease - surgery</subject><subject>Crohn's disease</subject><subject>Epigenetics</subject><subject>Female</subject><subject>Gene expression</subject><subject>Health risks</subject><subject>Humans</subject><subject>Ileum - diagnostic imaging</subject><subject>Inflammatory Bowel Disease</subject><subject>Male</subject><subject>MicroRNAs</subject><subject>MicroRNAs - blood</subject><subject>Middle Aged</subject><subject>Nomograms</subject><subject>Pathogenesis</subject><subject>Postoperative period</subject><subject>Reactive oxygen species</subject><subject>Recurrence</subject><subject>Risk Assessment</subject><subject>Tumor necrosis factor-TNF</subject><subject>Young Adult</subject><issn>2155-384X</issn><issn>2155-384X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkV1vFCEUhidGY5u1P0EziRd6MxUYmAEvTJr1q0nVzVYT7wjLHGaoDKwwY-OF_126W5u1JCdAeM57OOctiqcYnWJaI_FKT_0pOlwUNw-KY4IZq2pOvz88OB8VJyld7SBEuBCPi6OaNoKhmh4Xfy63oK2xulw5lUZVfrI6hvXns_LS9l5Nc4RUWl-uInRWT9b3pfJduQze2DjeXJcxDP5FKt_aBCpBuQY9xwhew-tyHRzs-JWahtCDz3XOx62zWk02-PSkeGSUS3Byuy-Kb-_ffV1-rC6-fDhfnl1UmnLKKt4wlAM4JVQZ3Gw06TYb1DAOLeKmA6MI47URusOtUIRQAaxukVEZM6quF8Wbve523ozQafBTVE5uox1V_C2DsvL_F28H2YdfkjPaijzyRfHyViCGnzOkSY42aXBOeQhzkrl8Q3NJijL6_B56Feboc3uStI0QbUMozxTbU3naKUUwd5_BSO48ltljed_jnPfssJO7rH-OZoDugevgJojph5uvIcoBlJsGiXBLEBK0IohgfCNa5cCs_guJqbOk</recordid><startdate>20211025</startdate><enddate>20211025</enddate><creator>Moret-Tatay, Inés</creator><creator>Cerrillo, Elena</creator><creator>Hervás, David</creator><creator>Iborra, Marisa</creator><creator>Sáez-González, Esteban</creator><creator>Forment, Javier</creator><creator>Tortosa, Luis</creator><creator>Nos, Pilar</creator><creator>Gadea, Jose</creator><creator>Beltrán, Belén</creator><general>Wolters Kluwer</general><general>Wolters Kluwer Health Medical Research, Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2086-1521</orcidid></search><sort><creationdate>20211025</creationdate><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><author>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Biomarkers</topic><topic>Colonoscopy</topic><topic>Colorectal surgery</topic><topic>Crohn Disease - blood</topic><topic>Crohn Disease - diagnostic imaging</topic><topic>Crohn Disease - genetics</topic><topic>Crohn Disease - surgery</topic><topic>Crohn's disease</topic><topic>Epigenetics</topic><topic>Female</topic><topic>Gene expression</topic><topic>Health risks</topic><topic>Humans</topic><topic>Ileum - diagnostic imaging</topic><topic>Inflammatory Bowel Disease</topic><topic>Male</topic><topic>MicroRNAs</topic><topic>MicroRNAs - blood</topic><topic>Middle Aged</topic><topic>Nomograms</topic><topic>Pathogenesis</topic><topic>Postoperative period</topic><topic>Reactive oxygen species</topic><topic>Recurrence</topic><topic>Risk Assessment</topic><topic>Tumor necrosis factor-TNF</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moret-Tatay, Inés</creatorcontrib><creatorcontrib>Cerrillo, Elena</creatorcontrib><creatorcontrib>Hervás, David</creatorcontrib><creatorcontrib>Iborra, Marisa</creatorcontrib><creatorcontrib>Sáez-González, Esteban</creatorcontrib><creatorcontrib>Forment, Javier</creatorcontrib><creatorcontrib>Tortosa, Luis</creatorcontrib><creatorcontrib>Nos, Pilar</creatorcontrib><creatorcontrib>Gadea, Jose</creatorcontrib><creatorcontrib>Beltrán, Belén</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and translational gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moret-Tatay, Inés</au><au>Cerrillo, Elena</au><au>Hervás, David</au><au>Iborra, Marisa</au><au>Sáez-González, Esteban</au><au>Forment, Javier</au><au>Tortosa, Luis</au><au>Nos, Pilar</au><au>Gadea, Jose</au><au>Beltrán, Belén</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</atitle><jtitle>Clinical and translational gastroenterology</jtitle><addtitle>Clin Transl Gastroenterol</addtitle><date>2021-10-25</date><risdate>2021</risdate><volume>12</volume><issue>10</issue><spage>e00416</spage><epage>e00416</epage><pages>e00416-e00416</pages><issn>2155-384X</issn><eissn>2155-384X</eissn><abstract>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications. Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used. Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year. Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</abstract><cop>United States</cop><pub>Wolters Kluwer</pub><pmid>34695034</pmid><doi>10.14309/ctg.0000000000000416</doi><orcidid>https://orcid.org/0000-0003-2086-1521</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2155-384X
ispartof Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00416-e00416
issn 2155-384X
2155-384X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8547914
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Biomarkers
Colonoscopy
Colorectal surgery
Crohn Disease - blood
Crohn Disease - diagnostic imaging
Crohn Disease - genetics
Crohn Disease - surgery
Crohn's disease
Epigenetics
Female
Gene expression
Health risks
Humans
Ileum - diagnostic imaging
Inflammatory Bowel Disease
Male
MicroRNAs
MicroRNAs - blood
Middle Aged
Nomograms
Pathogenesis
Postoperative period
Reactive oxygen species
Recurrence
Risk Assessment
Tumor necrosis factor-TNF
Young Adult
title Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T01%3A12%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20Plasma%20MicroRNA%20Signatures%20in%20Predicting%20and%20Confirming%20Crohn's%20Disease%20Recurrence:%20Role%20and%20Pathogenic%20Implications&rft.jtitle=Clinical%20and%20translational%20gastroenterology&rft.au=Moret-Tatay,%20In%C3%A9s&rft.date=2021-10-25&rft.volume=12&rft.issue=10&rft.spage=e00416&rft.epage=e00416&rft.pages=e00416-e00416&rft.issn=2155-384X&rft.eissn=2155-384X&rft_id=info:doi/10.14309/ctg.0000000000000416&rft_dat=%3Cproquest_pubme%3E2769976248%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2769976248&rft_id=info:pmid/34695034&rfr_iscdi=true